News & Events Press Releases Events & Presentations Year None20182017 08.30 2018 Translate Bio to Participate in Citi’s 13th Annual Biotech Conference 08.09 2018 Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements 07.09 2018 Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases 06.27 2018 Translate Bio Announces Pricing of Initial Public Offering 06.18 2018 Translate Bio Launches Proposed Initial Public Offering 06.11 2018 Translate Bio Announces Agreement with Sanofi Pasteur to Develop Vaccines for Infectious Diseases using Novel mRNA Technology 06.07 2018 Translate Bio to Present Preclinical Data at the 41st Annual European Cystic Fibrosis Conference 05.23 2018 Translate Bio Names John R. Schroer, CFA, Chief Financial Officer 04.12 2018 Translate Bio Announces FDA Clearance to Proceed with Phase 1/2 Clinical Trial in Patients with Cystic Fibrosis (CF) Upcoming Events 10.01 2018 Leerink Partners Rare Disease & Immuno-Oncology Roundtable 10.06 2018 Cystic Fibrosis Foundation’s CF Cycle for Life 10.17 2018 North American Cystic Fibrosis Conference 11.11 2018 6th International mRNA Health Conference Past Events 09.04 2018 Citi’s 13th Annual Biotech Conference 06.06 2018 41st Annual European Cystic Fibrosis Conference 06.04 2018 BIO International Convention 05.09 2018 TIDES 2018 04.24 2018 World Orphan Drug Congress USA 11.16 2017 The Cystic Fibrosis Foundation’s Uncork the Cure 11.01 2017 North American Cystic Fibrosis Conference 10.31 2017 5th International mRNA Health Conference 09.27 2017 Discovery on Target – Emerging Oligonucleotide Therapeutics 09.26 2017 2nd International Ataxia Research Conference Pagination Current page 1 Page 2 Next page next › Last page last »
